Agree Realty excels with strong underwriting, e-commerce-resistant tenants, and low leverage, ensuring stable AFFO and ...

Pfizer has been a big name in healthcare for decades, but it has been a largely underwhelming investment over the past 10 ...

Walgreens faces a potential buyout by Sycamore Partners amid declining profits and heavy debt. Click here to read my earnings preview of WBA stock now.

Analysts expect Walgreens Boots Alliance to report an earnings per share (EPS) of $0.34. Investors in Walgreens Boots Alliance are eagerly awaiting the company's announcement, hoping for news of ...

Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 7.2% year on year to $38.99 billion. Its non-GAAP profit of $0.

Detailed price information for Walgreens Boots Alliance (WBA-Q) from The Globe and Mail including charting and trades.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is an American multinational company providing retail, pharmacy, and healthcare ...

Investing.com - Mizuho reiterated its Outperform rating and $316.00 price target on Cencora Inc (NYSE: COR) Thursday following Walgreens’ quarterly earnings report. The target falls within the ...

US Stock futures ticked higher early Thursday, with the S&P 500 now just shy of its all-time high, gaining 0.3% in pre-market trading. The Nasdaq 100 futures rose 0.4%, while Dow Jones futures added ...

The Dow Jones Industrial Average was up around 4% in the first half of 2025 with a large majority of the 30 stocks positive.